In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5‐aminolevulinic acid

Previous studies with PhotoDynamic Therapy (PDT) in bladder and bronchi have shown that due to scattering and reflection, the actually delivered fluence rate on the surface in a hollow organ can be significantly higher than expected. In this pilot study, we investigated the differences between the primary calculated and the actual measured fluence rate during PDT of Barrett's Esophagus (BE) using 23 independent clinical measurements in 15 patients.

[1]  H. S. de Bruijn,et al.  Improvement of systemic 5-aminolevulinic acid-based photodynamic therapy in vivo using light fractionation with a 75-minute interval. , 1999, Cancer research.

[2]  P. Monnier,et al.  Light dosimetry for photodynamic therapy in the esophagus , 1997, Lasers in surgery and medicine.

[3]  W. Star,et al.  Calibration of isotropic light dosimetry probes based on scattering bulbs in clear media. , 1996, Physics in medicine and biology.

[4]  Masoud Panjehpour,et al.  Centering balloon to improve esophageal photodynamic therapy , 1992, Lasers in surgery and medicine.

[5]  E. G. Hahn,et al.  Photodynamic destruction of high grade dysplasia and early carcinoma of the esophagus after the oral administration of 5‐aminolevulinic acid , 1999, Cancer.

[6]  H. J. van Staveren,et al.  Integrating sphere effect in whole-bladder wall photodynamic therapy: III. Fluence multiplication, optical penetration and light distribution with an eccentric source for human bladder optical properties. , 1996, Physics in medicine and biology.

[7]  Rick E. Sneed,et al.  Comparative study between pulsed and continuous wave lasers for Photofrin® photodynamic therapy , 1993, Lasers in surgery and medicine.

[8]  P. Rehak,et al.  Palliation of advanced esophageal carcinoma by photodynamic therapy and irradiation. , 2000, The Annals of thoracic surgery.

[9]  H. Barr,et al.  Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia. , 1999, Journal of photochemistry and photobiology. B, Biology.

[10]  B. Overholt,et al.  Light sources and delivery devices for photodynamic therapy in the gastrointestinal tract. , 2000, Gastrointestinal endoscopy clinics of North America.

[11]  T. Stephenson,et al.  Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial , 2000, Gut.

[12]  R. van Hillegersberg,et al.  Kinetics, localization, and mechanism of 5‐aminolevulinic acid‐induced porphyrin accumulation in normal and Barrett's‐like rat esophagus , 1999, Lasers in surgery and medicine.

[13]  W. Star,et al.  Ex vivo light dosimetry and Monte Carlo simulations for endobronchial photodynamic therapy. , 1995, Physics in medicine and biology.

[14]  A Gorchein,et al.  Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study. , 1995, Gut.

[15]  H. J. van Staveren,et al.  Photodynamic therapy for esophageal lesions: selectivity depends on wavelength, power, and light dose. , 1999, The Annals of thoracic surgery.

[16]  B. Overholt,et al.  Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation , 2000, American Journal of Gastroenterology.

[17]  M. L. De Jode.  Monte Carlo simulations of the use of isotropic light dosimetry probes to monitor energy fluence in biological tissues. , 1999 .

[18]  H. Barr,et al.  Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX , 1996, The Lancet.

[19]  B F Overholt,et al.  Photodynamic therapy for esophageal cancer using a 180 degrees windowed esophageal balloon. , 1994, Lasers in surgery and medicine.

[20]  H. Barr,et al.  Barrett's esophagus: treatment with 5-aminolevulinic acid photodynamic therapy. , 2000, Gastrointestinal endoscopy clinics of North America.

[21]  H van den Bergh,et al.  On the Evolution of Some Endoscopic Light Delivery Systems for Photodynamic Therapy , 1998, Endoscopy.

[22]  Bergein F. Overholt,et al.  Photodynamic therapy for esophageal cancer using a 180° windowed esophageal balloon , 1994 .

[23]  Stanley B. Brown,et al.  Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological Effect , 1998, Photochemistry and photobiology.

[24]  Monte carlo simulations for endobronchial photodynamic therapy: The influence of variations in optical and geometrical properties and of realistic and eccentric light sources , 1998, Lasers in surgery and medicine.

[25]  A. May,et al.  A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia. , 1999, Endoscopy.

[26]  T. Stephenson,et al.  5‐Aminolevulinic Acid Photosensitization of Dysplastic Barrett's Esophagus: A Pharmacokinetic Study , 1999, Photochemistry and photobiology.